ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,267.84
-0.74%
Dow Jones
39,065.26
-1.53%
US Dollar vs MXN
16.74117
0.05%
Brent Oil
81.17
-0.17%
Bitcoin
67,812.52
-0.16%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Biohaven Ltd (BHVN)

  7. Biohaven Ltd (BHVN) Noticias

BHVN

Biohaven (BHVN)

Biohaven Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:BHVN
FechaHoraFuenteTítuloSímboloCompañía
17/05/202415:42Edgar (US Regulatory)Form 8-K - Current reportNYSE:BHVNBiohaven Ltd
17/05/202415:41Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NYSE:BHVNBiohaven Ltd
09/05/202415:16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:BHVNBiohaven Ltd
09/05/202415:05PR Newswire (US)Biohaven Reports First Quarter 2024 Financial Results and Recent Business DevelopmentsNYSE:BHVNBiohaven Ltd
22/04/202415:05PR Newswire (US)Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional SharesNYSE:BHVNBiohaven Ltd
17/04/202415:05PR Newswire (US)Biohaven Announces Proposed Public Offering of Common SharesNYSE:BHVNBiohaven Ltd
13/04/202408:00PR Newswire (US)Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business UpdatesNYSE:BHVNBiohaven Ltd
29/02/202415:05PR Newswire (US)Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business DevelopmentsNYSE:BHVNBiohaven Ltd
08/01/202406:30PR Newswire (US)Biohaven Highlights Progress Across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference; Established Extensive Portfolio Across 20 Therapeutic Indications in Neuroscience, Immunology and OncoloNYSE:BHVNBiohaven Ltd
02/01/202406:00PR Newswire (US)Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:BHVNBiohaven Ltd
01/12/202315:30PR Newswire (US)Biohaven Presents Expanded EEG and Safety Data for BHV-7000 at the American Epilepsy Society Annual MeetingNYSE:BHVNBiohaven Ltd
14/11/202315:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:BHVNBiohaven Ltd
14/11/202315:05PR Newswire (US)Biohaven Reports Third Quarter 2023 Financial Results and Recent Business DevelopmentsNYSE:BHVNBiohaven Ltd
16/10/202306:00PR Newswire (US)Biohaven Presents Preclinical Data Demonstrating Taldefgrobep alfa Reduces Fat and Improves Lean Mass at The Obesity Society's Annual Meeting, ObesityWeek®NYSE:BHVNBiohaven Ltd
04/10/202315:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:BHVNBiohaven Ltd
02/10/202322:56PR Newswire (US)Biohaven Announces Pricing of $225 Million Public Offering of Common SharesNYSE:BHVNBiohaven Ltd
02/10/202315:36PR Newswire (US)BIOHAVEN ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARESNYSE:BHVNBiohaven Ltd
02/10/202315:01Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:BHVNBiohaven Ltd
14/09/202306:00PR Newswire (US)Biohaven Completes Enrollment in Pivotal Phase 3 Study of Taldefgrobep Alfa in Spinal Muscular AtrophyNYSE:BHVNBiohaven Ltd
05/09/202306:00PR Newswire (US)Biohaven Announces Positive Data from its Exploratory Electroencephalogram (EEG) Biomarker Study of BHV-7000, Completion of Once-Daily Formulation Development, and Plan to Initiate Phase 3 Pivotal StudiesNYSE:BHVNBiohaven Ltd
31/07/202308:31PR Newswire (US)Biohaven's Taldefgrobep Alfa Receives EU Orphan Drug Designation for Spinal Muscular AtrophyNYSE:BHVNBiohaven Ltd
31/07/202305:59PR Newswire (US)Biohaven Reports Second Quarter 2023 Financial Results and Recent Business DevelopmentsNYSE:BHVNBiohaven Ltd
27/07/202307:42Dow Jones NewsBiohaven Told That FDA Won't Review NDA Application for TroriluzoleNYSE:BHVNBiohaven Ltd
27/07/202306:00PR Newswire (US)Biohaven Provides Preliminary EEG Data Update for Kv7 Platform, Regulatory Update on Troriluzole and Other Corporate UpdatesNYSE:BHVNBiohaven Ltd
31/05/202306:04Edgar (US Regulatory)Current Report Filing (8-k)NYSE:BHVNBiohaven Ltd
31/05/202306:00PR Newswire (US)Biohaven Provides Overview of Clinical Progress, Regulatory Updates, and Pipeline Developments at R&D DayNYSE:BHVNBiohaven Ltd
25/05/202316:00PR Newswire (US)Biohaven to Present R&D Day at Yale School of ManagementNYSE:BHVNBiohaven Ltd
12/05/202315:43Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NYSE:BHVNBiohaven Ltd
12/05/202315:30PR Newswire (US)Biohaven Reports First Quarter 2023 Financial Results and Reports Recent Business DevelopmentsNYSE:BHVNBiohaven Ltd
04/05/202316:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:BHVNBiohaven Ltd
 Showing the most relevant articles for your search:NYSE:BHVN

Su Consulta Reciente

EU
EUED5
ESGL US 20 D
BIT
UB8PEP
Unicredit Bank
ASX
MBKDB
Metal Bank
KOSPI
33626L
Doosan Fuel Cell
EU
SNAV
SNCF Reseau 2.777% Coupo...
LSE
AEY
LSE
59MQ
Edp Fin.23
TSXV
GVR
Grosvenor Resource
GATE
SNTBTC
StatusNetwork
LSE
FK45
Barclays 28
NASDAQ
DXPS
AMEX
FNI
First Trust Chindia ETF
NASDAQ
FMDHXX
Us Infrastructure Portfo...
BINA
CVCUSDT
Civic
LSE
VOX
Vox Valor Capital
BIT
UV4LUF
UniCredit Bank
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados